MacMillan to DePuySynthes? (Walter Eisner @ OTW)
First The Wall Street Journal reported that the former Stryker Corporation CEO was gunning for a job with his old employer, Johnson & Johnson. Now Massdevice.com reported on June 13, that with the DePuySynthes merger completed and rumors of Steve MacMillan "looking like a good fit" to run the new ortho business, would his two-year non-compete agreement with Stryker stand in the way?
The two-year non-compete clause MacMillan signed with Stryker in his February 2012 separation agreement, which paid him $5.5 million in cash and the rights to pu...
